Loretta M. Wedge - 18 May 2022 Form 4/A - Amendment Insider Report for Biofrontera Inc. (BFRI)

Role: Director
Signature: /s/Daniel Hakansson, Attorney-in-fact for Loretta M. Wedge
Issuer symbol: BFRI
Transactions as of: 18 May 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 06 Jun 2022, 19:38:14 UTC
Date Of Original Report: 26 May 2022
Previous filing: 02 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BFRI	Employee stock option (right to buy)	Award	$0	+22,000		$0.000000	22,000	18 May 2022	Common Stock	22,000	$2.61	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in twelve equal monthly installments beginning June 18, 2022.

Remarks:

The Form 4, as originally filed on 5/26/2022, inadvertently reported an incorrect vesting schedule of three equal annual installments beginning May 18, 2023.